A multi-center study of ACE and the risk of late-onset Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 24, Issue 3, 2011, Pages 587-597

  Belbin, Olivia ^a,b   Brown, Kristelle ^a   Shi, Hui ^a   Medway, Christopher ^a   Abraham, Richard ^c   Passmore, Peter ^d   Mann, David ^e   Smith, A David ^f   Holmes, Clive ^g   McGuinness, Bernadette ^d   Craig, David ^d   Warden, Donald ^g   Heun, Reinhard ^h   Kölsch, Heike ⁱ   Love, Seth ^j   Kalsheker, Noor ^a   Williams, Julie ^c   Owen, Michael J ^c   Carrasquillo, Minerva ^b   Younkin, Steven ^b   Morgan, Kevin ^a   Kehoe, Patrick G ^j   more..

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b MAYO GRADUATE SCHOOL   (United States)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h QUEEN ELIZABETH PSYCHIATRIC HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF BONN   (Germany)

^j UNIVERSITY OF BRISTOL   (United Kingdom)

more..

Author keywords

Alzheimer's disease; angiotensin 1 converting enzyme; haplotype; heterogeneity; late onset; meta analysis

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 4; DIPEPTIDYL CARBOXYPEPTIDASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; ETHNICITY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; LATE ONSET ALZHEIMER DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL;

EID: 79957822796     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-101914     Document Type: Article

References (51)

1. Walsh DM, Selkoe DJ (2004) Deciphering the molecular basis of memory failure in Alzheimers disease. Neuron 44, 181-193. (Pubitemid 39348839)
2. Love S, Miners S, Palmer J, Chalmers K, Kehoe P (2009) Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy. Front Biosci 14, 4778-4792.
3. Miners JS, Baig S, Palmer J, Palmer LE, Kehoe PG, Love S (2008) Abeta-degrading enzymes in Alzheimers disease. Brain Pathol 18, 240-252.
4. Kehoe PG, Miners S, Love S (2009) Angiotensins in Alzheimers disease -friend or foe? Trends Neurosci 32, 619-628.
5. Kehoe PG (2009) Angiotensins and Alzheimers disease: a bench to bedside overview. Alzheimers Res Ther 1, 3.
6. Vardy ER, Rice PJ, Bowie PC, Holmes JD, Catto AJ, Hooper NM (2009) Plasma angiotensin-converting enzyme in Alzheimers disease. J Alzheimers Dis 16, 609-618.
7. Kauwe JS, Wang J, Mayo K, Morris JC, Fagan AM, Holtzman DM, Goate AM (2009) Alzheimers disease risk variants show association with cerebrospinal fluid amyloid beta. Neurogenetics 10, 13-17.
8. Kehoe PG, Katzov H, Feuk L, Bennet AM, Johansson B, Wiman B, de Faire U, Cairns NJ, Wilcock GK, Brookes AJ, Blennow K, Prince JA (2003) Haplotypes extending across ACEare associated with Alzheimers disease.HumMol Genet 12, 859-867. (Pubitemid 36504028)
9. Cambien F, Alhenc-Gelas F, Herbeth B, Andre JL, Rakotovao R, Gonzales MF, Allegrini J, Bloch C (1988) Familial resemblance of plasma angiotensin- converting enzyme level: the Nancy Study.AmJ Hum Genet 43, 774-780. (Pubitemid 18269261)
10. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86, 1343-1346. (Pubitemid 20370444)
11. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F (1992) Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51, 197-205.
12. Lehman DM, Fu DJ, Freeman AB, Hunt KJ, Leach RJ, Johnson-Pais T, Hamlington J, Dyer TD, Arya R, Abboud H, Goring HH, Duggirala R, Blangero J, Konrad RJ, Stern MP (2005) A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-D glucosaminidase is associated with type 2 diabetes in Mexican Americans. Diabetes 54, 1214-1221. (Pubitemid 40446339)
13. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimers disease in late onset families. Science 261, 921-923. (Pubitemid 23275809)
14. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, et al. (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimers disease. Neurology 43, 1467-1472. (Pubitemid 23230526)
15. Bertram L, McQueen M, Mullin K, Blacker D, Tanzi R (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39, 17-23. (Pubitemid 46026496)
16. Katzov H, Bennet AM, Kehoe P,Wiman B, Gatz M, Blennow K, Lenhard B, Pedersen NL, de Faire U, Prince JA (2004) A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity. Hum Mol Genet 13, 2647-2657. (Pubitemid 39485413)
17. Meng Y, Baldwin CT, Bowirrat A, Waraska K, Inzelberg R, Friedland RP, Farrer LA (2006) Association of polymorphisms in the Angiotensin-converting enzyme gene with Alzheimer disease in an Israeli Arab community. Am J Hum Genet 78, 871-877.
18. Schjeide BM, McQueen MB, Mullin K, DiVito J, Hogan MF, ParkinsonM,Hooli B, Lange C, Blacker D,Tanzi RE, Bertram L (2009) Assessment of Alzheimers disease case-control associations using family-based methods. Neurogenetics 10, 19-25.
19. Keavney B,McKenzie CA, Connell JM, Julier C, Ratcliffe PJ, Sobel E, Lathrop M, Farrall M (1998) Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum Mol Genet 7, 1745-1751. (Pubitemid 28464149)
20. Soubrier F, Martin S, Alonso A, Visvikis S, Tiret L, Matsuda F, Lathrop GM, Farrall M (2002) High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity. Eur J Hum Genet 10, 553-561. (Pubitemid 35012310)
21. Rieder MJ, Taylor SL, Clark AG, Nickerson DA (1999) Sequence variation in the human angiotensin converting enzyme. Nat Genet 22, 59-62. (Pubitemid 29214805)
22. Kehoe PG, Russ C, McIlory S, Williams H, Holmans P, Holmes C, Liolitsa D, Vahidassr D, Powell J, McGleenon B, Liddell M, Plomin R, Dynan K, Williams N, Neal J, Cairns NJ, Wilcock G, Passmore P, Lovestone S, Williams J, Owen MJ (1999) Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat Genet 21, 71-72. (Pubitemid 29036286)
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimers disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimers Disease. Neurology 34, 939-944. (Pubitemid 14076461)
24. Mirra SS, Hart MN, Terry RD (1993) Making the diagnosis of Alzheimers disease. A primer for practicing pathologists. Arch Pathol Lab Med 117, 132-144. (Pubitemid 23057613)
25. Morgan AR, Hamilton G, Turic D, Jehu L, Harold D, Abraham R, Hollingworth P, Moskvina V, Brayne C, Rubinsztein DC, Lynch A, Lawlor B, Gill M, ODonovan M, Powell J, Lovestone S, Williams J, Owen MJ (2008) Association analysis of 528 intra-genic SNPs in a region of chromosome 10 linked to late onset Alzheimers disease. Am J Med Genet B Neuropsychiatr Genet 147B, 727-731.
26. Wigginton JE, Cutler DJ, AbecasisGR(2005)Anote on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 76, 887-893. (Pubitemid 40563110)
27. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 559-575. (Pubitemid 47330214)
28. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70, 425-434. (Pubitemid 34112296)
29. Alvarez R, Alvarez V, Lahoz CH, Martinez C, Pena J, Sanchez JM, Guisasola LM, Salas-Puig J, Moris G, Vidal JA, Ribacoba R, Menes BB, Uria D, Coto E (1999) Angiotensin converting enzyme and endothelial nitric oxide synthaseDNA polymorphisms and late onset Alzheimers disease. J Neurol Neurosurg Psychiatry 67, 733-736.
30. Edwards TL, Pericak-Vance M, Gilbert JR, Haines JL, Martin ER, RitchieMD(2009) An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2 M, and LRRTM3. Am J Med Genet B Neuropsychiatr Genet 150B, 721-735.
31. Ghebranious N, Mukesh B, Giampietro PF, Glurich I, Mickel SF, Waring SC, McCarty CA (2010) A Pilot Study of Gene/Gene and Gene/Environment Interactions in Alzheimer Disease. Clin Med Res. doi:10.3121/cmr.2010.894
32. Helbecque N, Codron V, Cottel D, Amouyel P (2009) An age effect on the association of common variants of ACE with Alzheimers disease. Neurosci Lett 461, 181-184.
33. Kolsch H, Jessen F, Freymann N, Kreis M, Hentschel F, Maier W, Heun R (2005) ACE I/D polymorphism is a risk factor of Alzheimers disease but not of vascular dementia. Neurosci Lett 377, 37-39. (Pubitemid 40255635)
34. Mattila KM, Rinne JO, Roytta M, Laippala P, Pietila T, Kalimo H, Koivula T, Frey H, Lehtimaki T (2000) Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimers disease and in Parkinsons disease with coexisting Alzheimer pathology. JMed Genet 37, 766-770.
35. Corneveaux JJ, Liang WS, Reiman EM, Webster JA, Myers AJ, Zismann VL, Joshipura KD, Pearson JV, Hu-Lince D, Craig DW, Coon KD, Dunckley T, Bandy D, Lee W, Chen K, Beach TG, Mastroeni D, Grover A, Ravid R, Sando SB, Aasly JO, Heun R, Jessen F, Kolsch H, Rogers J, Hutton ML, Melquist S, Petersen RC, Alexander GE, Caselli RJ, Papassotiropoulos A, Stephan DA, Huentelman MJ (2010) Evidence for an association between KIBRA and late-onset Alzheimers disease. Neurobiol Aging 31, 901-909.
36. Bruandet A, Richard F, Tzourio C, Berr C, Dartigues JF, Alperovitch A, Amouyel P, Helbecque N (2008) Haplotypes across ACE and the risk of Alzheimers disease: the three-city study. J Alzheimers Dis 13, 333-339. (Pubitemid 352039035)
37. Cousin E, Mace S, Rocher C, Dib C, Muzard G, Hannequin D, Pradier L, Deleuze JF, Genin E, Brice A, Campion D (2009) No replication of genetic association between candidate polymorphisms and Alzheimers disease. Neurobiol Aging. doi:10.1016/j.neurobiolaging.2009.09.004
38. Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, Engel A, Nalls MA, Chen K, Lee W, Chewning K, Villa SE, Meechoovet HB, Gerber JD, Frost D, Benson HL, OReilly S, Chibnik LB, Shulman JM, Singleton AB, Craig DW, van Keuren-Jensen KR, Dunckley T, Bennett DA, De Jager PL, Heward C, Hardy J, Reiman EM, Huentelman MJ (2010) Association of CR1, CLU and PICALM with Alzheimers disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet 19, 3295-3301.
39. Shulman JM, Chibnik LB, Aubin C, Schneider JA, Bennett DA, De Jager PL (2010) Intermediate phenotypes identify divergent pathways to Alzheimers disease. PLoS One 5, e11244.
40. Miners JS, Ashby E, van Helmond Z, Chalmers KA, Palmer LE, Love S,Kehoe PG (2008) Angiotensin-converting enzyme (ACE) levels and activity in Alzheimers disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 34, 181-193. (Pubitemid 351327960)
41. Miners JS, van Helmond Z, Raiker M, Love S, Kehoe PG (2011) ACE variants and association with brain A? levels in Alzheimers disease. Am J Transl Res 3, 71-78.
42. Miners S, Ashby E, Baig S, Harrison R, Tayler H, Speedy E, Prince JA, Love S, Kehoe PG (2009) Angiotensin-converting enzyme levels and activity in Alzheimers disease: differences in brain and CSF ACE and association with ACE1 genotypes. Am J Transl Res 1, 163-177.
43. Ellul J, Archer N, Foy CM, Poppe M, Boothby H, Nicholas H, Brown RG, Lovestone S (2007) The effects of commonly prescribed drugs in patients with Alzheimers disease on the rate of deterioration. J Neurol Neurosurg Psychiatry 78, 233-239. (Pubitemid 46579658)
44. Chung CM, Wang RY, Chen JW, Fann CS, Leu HB, Ho HY, Ting CT, Lin TH, Sheu SH, Tsai WC, Chen JH, Jong YS, Lin SJ, Chen YT, Pan WH (2010) A genome-wide association study identifies new loci for ACE activity: potential implications for response to ACE inhibitor. Pharmacogenomics J 10, 537-544.
45. Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC, Tschanz JT, Mayer LS,Welsh-Bohmer KA, Breitner JC (2006) Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol 63, 686-692.
46. Li NC, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE, Wolozin B (2010) Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ 340, b5465.
47. Ohrui T, Matsui T, Yamaya M, Arai H, Ebihara S, Maruyama M, Sasaki H (2004) Angiotensin-converting enzyme inhibitors and incidence of Alzheimers disease in Japan. J Am Geriatr Soc 52, 649-650. (Pubitemid 38480653)
48. Ohrui T, Tomita N, Sato-Nakagawa T, Matsui T, Maruyama M, Niwa K, Arai H, Sasaki H (2004) Effects of brain penetrating ACE inhibitors on Alzheimer disease progression. Neurology 63, 1324-1325. (Pubitemid 39350046)
49. Rozzini L, Chilovi BV, Bertoletti E, Conti M, Del Rio I, Trabucchi M, Padovani A (2006) Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment. Int J Geriatr Psychiatry 21, 550-555. (Pubitemid 44043756)
50. Rozzini L, Vicini Chilovi B, Trabucchi M, Padovani A (2008) Antihypertensive medications influence the rate of conversion from mild cognitive impairment to Alzheimer disease. Arch Neurol 65, 993-994; author reply 994-995. (Pubitemid 352008496)
51. Sink KM, Leng X, Williamson J, Kritchevsky SB, Yaffe K, Kuller L, Yasar S, Atkinson H, Robbins M, Psaty B, Goff DC Jr (2009) Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study. Arch Intern Med 169, 1195-1202.